4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001415889-24-015533
CHIEF BUSINESS OFFICER AND COO acquired 56,061 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hannah Brendan CHIEF BUSINESS OFFICER AND COO | 2024-06-04 | Option exercise | +56,061 | $0.55 | $30,834 | 257,616 | D |
| Derivatives | |||||||
| Hannah Brendan CHIEF BUSINESS OFFICER AND COO | 2024-06-04 | Option exercise · Employee Stock Option (right to buy) | −56,061 | 47,439 | D | ||
Loading xslF345X05/form4-06052024_060635.xml…